Search Results
Found 1 results
510(k) Data Aggregation
(81 days)
is intended for the quantitative determination of thyroglobulin (Tg) in human serum as an aid in the detection of local and metastatic thyroid tissue in patients who have had thyroid gland ablation (using thyroid surgery with or without radioiodine), and who lack serum thyroglobulin antibodies.
Not Found
I am sorry, but the provided text from the FDA document does not contain information about acceptance criteria or a study that proves a device meets such criteria. The document is primarily a notification letter from the FDA regarding the substantial equivalence of the "Kronus Optiquant Thyroglobulin Kit" to a legally marketed predicate device, allowing it to be marketed. It discusses regulatory classifications, general controls, and points of contact for additional information.
Therefore, I cannot fulfill your request to describe the acceptance criteria and the study based on the provided text.
Ask a specific question about this device
Page 1 of 1